Calithera Biosciences (NASDAQ:CALA) Coverage Initiated at StockNews.com

Equities research analysts at StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a research report issued on Wednesday. The firm set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Price Performance

Shares of CALA stock opened at $0.00 on Wednesday. Calithera Biosciences has a fifty-two week low of $0.00 and a fifty-two week high of $0.12.

About Calithera Biosciences

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.